Clinical Trial Update: Berberine Treat Metabolic Syndrome in Schizophrenia [NA]

View source ↗

Summary

A completed clinical trial from Tianjin Anding Hospital evaluated berberine for metabolic syndrome in individuals with schizophrenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Syndrome
• Schizophrenia

Drugs mentioned

• Berberine (berberine)

Snippet

Sponsor: Tianjin Anding Hospital | Conditions: Metabolic Syndrome, Female | NA | Status: COMPLETED